Stocktoria
InspireMD, Inc. NSPR
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2013-04-12
InspireMD, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 29.5% | 21.5% | 29.1% | 21.6% | 16.8% |
| Operating margin | -552.6% | -478.0% | -340.7% | -361.9% | -327.4% |
| Net margin | -543.3% | -456.6% | -321.0% | -357.6% | -331.9% |
| FCF margin | -409.5% | -332.0% | -270.1% | -309.7% | -301.5% |
| Return on assets | -70.3% | -68.4% | -41.8% | -75.0% | -37.6% |
| Return on equity | -88.4% | -88.7% | -50.4% | -106.3% | -44.5% |
| Current ratio | 5.74 | 5.28 | 7.34 | 4.21 | 8.53 |
| Revenue growth | 28.1% | 13.0% | 20.0% | 15.0% | 80.9% |
Source: SEC EDGAR filings · CIK 0001433607 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.